Does the EQ-5D measure quality of life in schizophrenia?

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Mental Health Policy and Economics

• Publication date

  2011-12-01

• Fields of study

  Medicine, Economics, Psychology

• Identifiers
  PMID 22345360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How Valid and Responsive Are Generic Health Status Measures, such as EQ-5D and SF-36, in Schizophrenia? A Systematic Review

  2011cited by this paper
• Cost-effectiveness of an early intervention service for people with psychosis

  2010cited by this paper
• Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders

  2010cited by this paper
• Is the EQ–5D fit for purpose in mental health?

  2010cited by this paper
• Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders

  2010cited by this paper
• Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - a systematic review.

  2009cited by this paper
• A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.

  2009cited by this paper
• The EQ-5D: A useful quality of life measure in borderline personality disorder?

  2009cited by this paper
• Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ–5D

  2009cited by this paper
• Measuring and valuing mental health for use in economic evaluation

  2008cited by this paper
• Design paper: The CapOpus trial: A randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis

  2008cited by this paper
• Cost-effectiveness analysis in severe mental illness: outcome measures selection.

  2007cited by this paper
• Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders

  2007cited by this paper
• Impact of psychiatric disorders on health-related quality of life: general population survey

  2007cited by this paper
• Social outcomes in schizophrenia

  2007cited by this paper
• Health economic measures in schizophrenia research

  2007cited by this paper
• Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review

  2006cited by this paper
• Comparison of EQ-5D and SF-6D utilities in mental health patients.

  2006cited by this paper
• Measuring health-related quality of life in bipolar disorder: Relationship of the EuroQol (EQ-5D) to condition-specific measures

  2006cited by this paper
• Quality of life measures in schizophrenia

  2005cited by this paper
• What does the PANSS mean?

  2005cited by this paper
• Changes in quality of life in chronic psychiatric patients: A comparison between EuroQol (EQ-5D) and WHOQoL

  2005cited by this paper
• Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores.

  2004cited by this paper
• Correlates of insight in first episode psychosis.

  2004cited by this paper
• Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients

  2004cited by this paper
• Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL.

  2003cited by this paper
• Quality of life in schizophrenia measured by the MOS SF‐36 and the Lancashire Quality of Life Profile: a comparison

  2002cited by this paper
• Symptom correlates of global measures of severity in schizophrenia.

  1999cited by this paper
• Application and Results of the Manchester Short Assessment of Quality of Life (Mansa)

  1999cited by this paper
• QALYs and mental health care

  1997cited by this paper
• Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile

  1997cited by this paper
• The World Health Organization Short Disability Assessment Schedule (WHO DAS-S): a tool for the assessment of difficulties in selected areas of functioning of patients with mental disorders

  1996cited by this paper
• Reliability and validity of the positive and negative syndrome scale for schizophrenics.

  1988cited by this paper
• Measurement of health state utilities for economic appraisal.

  1986cited by this paper
• The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome.

  1984cited by this paper

• HIF-1 signaling in myocardial infarction: Gene regulatory networks, cellular adaptation, and emerging therapeutic directions

  2026cites this paper
• Demonstrating the Cost Effectiveness of Individualised Occupational Therapy Interventions to Enable Transition from Institutional to Independent Living – A Longitudinal Case Study

  2023cites this paper
• Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes.

  2023cites this paper
• Comparison of capability and health-related quality of life instruments in capturing aspects of mental well-being in people with schizophrenia and depression

  2022cites this paper
• Assessment of Quality of Life 8-Dimension (AQoL-8D): translation, validation, and application in two Dutch trials in patients with epilepsy and schizophrenia

  2021cites this paper
• Pharmacotherapy Follow up in Mental Health: Which Outcomes Change in a Short Period?

  2020cites this paper
• Do alternative capability instruments capture differing aspects of mental health and quality of life in comparison to the EQ-5D for schizophrenic patients with depression?

  2020cites this paper
• Health State Utility Values in Schizophrenia: A Systematic Review and Meta-Analysis.

  2020cites this paper
• ICER, ISPOR AND QALYs: Tales of Imaginary Worlds

  2019cites this paper
• Self‐reported pain in patients with schizophrenia. Results from the national first‐step FACE‐SZ cohort

  2018cites this paper
• The impact of depression on health-related quality of life and wellbeing: identifying important dimensions and assessing their inclusion in multi-attribute utility instruments

  2018cites this paper
• TAILOR – tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial

  2017cites this paper
• Cost-Effectiveness Analysis

  2017cites this paper
• World Health Organization disability assessment schedule 2.0: An international systematic review

  2017cites this paper
• Research application (phase 2) for Innovation Fund Denmark, Grand Solutions: BeReal - Better lives trough bodily-emotionally sensed reality

  2016cites this paper
• Measuring quality of life in mental health: Are we asking the right questions?

  2014cites this paper
• Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial

  2012cites this paper